# LLM Judge Evaluation: tier1_001

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
Completion: The agent launched a solubility workflow for water at 310.15 K but never retrieved a result. The last status check showed RUNNING, and no numerical prediction was presented, nor any interpretation.

Correctness: No computed value was produced, so accuracy cannot be evaluated. Additionally, the SMILES used corresponds to a molecule with MW ≈1137 (C49H61N12O16PS), not remdesivir (MW 602.58; C27H35N6O8P), guaranteeing any eventual result would be for the wrong structure. PubChem (CID 121304016) shows the correct canonical SMILES and composition for remdesivir. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/121304016?utm_source=openai))

Tool use: Multiple critical failures:
- Could not map the common name “remdesivir” to a valid structure via the lookup tool, then proceeded without correcting.
- Submitted an invalid SMILES (wrong compound; MW ~1137 vs 602), which was “validated” and then used as the workflow input.
- Never completed the workflow or fetched results.

For literature context, remdesivir is essentially insoluble in water at neutral pH: a patent reports 0.0009 mg/mL at pH 6.18 and ~0 mg/mL at pH 6.72, and vendors/ACS list it as insoluble/very slightly soluble; a research article cites 0.028 mg/mL at room temperature (likely method/pH dependent). These corroborate its very low aqueous solubility and the need for SBECD in IV formulations. ([patents.justia.com](https://patents.justia.com/patent/20230355649?utm_source=openai))

### Feedback:
- Map the molecule correctly before any computation. Retrieve the canonical SMILES for remdesivir (PubChem CID 121304016) and verify MW/formula (C27H35N6O8P; 602.58 g/mol) match. ([pubchemlite.lcsb.uni.lu](https://pubchemlite.lcsb.uni.lu/e/compound/121304016?utm_source=openai))
- Do not proceed with a workflow if name-to-SMILES resolution fails. Escalate to alternative identifiers (CAS RN 1809249-37-3) or curated sources (DrugBank, PubChem) to obtain the correct structure. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Remdesivir?utm_source=openai))
- After submission, poll until completion and then fetch and report the numerical result with units and conditions.
- Provide immediate sanity checks: compare predicted solubility order of magnitude against literature (expected ≪0.1 mg/mL at neutral pH; often described as “insoluble/very slightly soluble”) to catch obvious input errors early. ([patents.justia.com](https://patents.justia.com/patent/20230355649?utm_source=openai))
- Literature validation: 1) Agent’s computed value: None (workflow never completed; moreover, the submitted SMILES was not remdesivir: MW 1137 vs true MW 602.58).

2) Literature value(s) for aqueous solubility:
- Near-neutral pH (aqueous HCl, pH 6.18): 0.0009 mg/mL; pH 6.72: ~0 mg/mL. Source: US patent application on remdesivir formulations. ([patents.justia.com](https://patents.justia.com/patent/20230355649?utm_source=openai))
- General aqueous solubility (room temperature): 0.028 mg/mL, reported in a peer‑reviewed article (value cited therein). ([pmc.ncbi.nlm.nih.gov](https://pmc.ncbi.nlm.nih.gov/articles/PMC9364662/?utm_source=openai))
- Qualitative confirmations: “insoluble” or “very slightly soluble in water” (ACS; vendor datasheets). ([acs.org](https://www.acs.org/molecule-of-the-week/archive/r/remdesivir.html?utm_source=openai))

3) Absolute error: N/A (no agent result).

4) Percent error: N/A (no agent result).

5) Score justification: With no numerical prediction, correctness cannot be assessed; furthermore, the input structure was incorrect, so any eventual result would not correspond to remdesivir.

### Web Search Citations:
1. [PubChemLite - Remdesivir (C27H35N6O8P)](https://pubchemlite.lcsb.uni.lu/e/compound/121304016?utm_source=openai)
2. [US Patent Application for FORMULATIONS OF ANTI-VIRAL COMPOUNDS Patent Application (Application #20230355649 issued November 9, 2023) - Justia Patents Search](https://patents.justia.com/patent/20230355649?utm_source=openai)
3. [US Patent Application for FORMULATIONS OF ANTI-VIRAL COMPOUNDS Patent Application (Application #20230355649 issued November 9, 2023) - Justia Patents Search](https://patents.justia.com/patent/20230355649?utm_source=openai)
4. [Remdesivir-loaded bis-MPA hyperbranched dendritic nanocarriers for pulmonary delivery - PMC](https://pmc.ncbi.nlm.nih.gov/articles/PMC9364662/?utm_source=openai)
5. [Remdesivir - American Chemical Society](https://www.acs.org/molecule-of-the-week/archive/r/remdesivir.html?utm_source=openai)
6. [PubChemLite - Remdesivir (C27H35N6O8P)](https://pubchemlite.lcsb.uni.lu/e/compound/121304016?utm_source=openai)
7. [Remdesivir](https://en.wikipedia.org/wiki/Remdesivir?utm_source=openai)
8. [US Patent Application for FORMULATIONS OF ANTI-VIRAL COMPOUNDS Patent Application (Application #20230355649 issued November 9, 2023) - Justia Patents Search](https://patents.justia.com/patent/20230355649?utm_source=openai)

### Execution:
- **Tools**: validate_smiles, workflow_get_status, molecule_lookup, batch_molecule_lookup, submit_solubility_workflow
- **Time**: 1.3 min

---
*Evaluated with openai/gpt-5*
